✦ LIBER ✦

Trastuzumab tallies up in HER2+ breast cancer

✍ Scribed by Pene, S

Book ID: 120844925
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 184 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200716140-00024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tanespimycin + trastuzumab promising in

Tanespimycin + trastuzumab promising in HER 2+ breast cancer

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB

Trastuzumab cost effective in HER2-posit

Trastuzumab cost effective in HER2-positive breast cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 125 KB

Trastuzumab cost effective in HER2-posit

Trastuzumab cost effective in HER2-positive breast cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 126 KB

Adjuvant trastuzumab for HER2-positive b

Adjuvant trastuzumab for HER2-positive breast cancer

✍ James Spicer; Mark Harries; Paul Ellis 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 47 KB

Trastuzumab after Adjuvant Chemotherapy

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

✍ Piccart-Gebhart, Martine J.; Procter, Marion; Leyland-Jones, Brian; Goldhirsch, 📂 Article 📅 2005 🏛 Massachusetts Medical Society 🌐 English ⚖ 149 KB